Exelixis, inc. (EXEL)
CashFlow / TTM
Apr'20Jan'20Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Jan'16Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11
Cash flows from operating activities:
Net income

293,849

321,012

612,358

641,536

649,988

690,070

368,470

323,222

253,384

154,227

150,861

58,195

5,701

-70,222

-146,913

-177,273

-185,797

-161,744

-170,884

-191,800

-221,848

-261,297

-281,335

-285,899

-274,650

-244,760

-226,207

-191,897

-166,223

-147,645

-49,156

61,523

77,036

75,697

0

0

0

Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation

8,561

8,348

8,127

7,737

6,506

4,915

3,221

1,800

1,277

1,187

1,090

1,109

1,054

1,002

1,097

1,178

1,338

1,406

440

1,982

2,190

2,391

3,779

2,612

2,803

3,147

3,824

4,501

5,122

5,513

5,858

5,533

6,126

6,822

0

0

0

Stock-based compensation

58,055

56,602

53,043

49,646

43,850

40,626

37,239

32,786

28,530

23,938

19,595

17,909

16,440

22,912

24,903

33,326

31,502

21,977

16,972

5,660

7,908

10,006

11,982

14,166

13,110

12,031

11,114

10,116

9,180

8,833

8,912

9,986

10,828

12,099

0

0

0

Non-cash lease expense

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred taxes

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

401(k) matching contributions made in common stock

-

-

-

-

-

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Amortization and other right-of-use assets

-

-

-

-

-

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Amortization of debt discounts and debt issuance costs

-

-

-

-

-

-

-

-

-

-

319

2,203

5,360

8,432

11,062

8,561

12,527

17,041

14,737

22,864

22,976

22,289

28,671

27,813

26,964

26,290

25,573

23,068

18,873

14,752

22,513

16,282

12,060

7,989

0

0

0

Restructuring charge for property and equipment

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-23

-192

180

497

0

0

0

Interest paid in kind

-

-

-

-

-

-

-

-

-

-

-9,756

-7,725

8,140

8,008

7,866

7,725

5,753

3,817

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Gain on other equity investments

-

-

-

-

-

-

0

0

3,189

-

0

0

0

-

-

-

-

112

95

933

933

838

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Changes in warrant fair value

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

548

625

563

448

-1,840

-1,916

-1,854

-1,739

0

0

0

0

-

-

-

-

-

-

-

-

Other, net

1,854

-88

1,418

1,300

-2,341

-1,129

8,375

7,433

7,633

6,795

613

211

-802

-562

-1,855

-1,689

-1,664

-1,861

-1,897

-2,639

-3,323

-4,161

-5,146

-5,760

-6,529

-6,787

-5,832

-5,315

-4,468

-4,039

-4,614

-5,385

-5,627

-4,801

0

0

0

Changes in operating assets and liabilities:
Trade receivables, net

29,655

-43,716

79,781

-56,457

19,551

85,471

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Trade and other receivables

-

-

-

-

-

-

0

0

4,017

-

-39,147

-12,331

-14,859

-3,362

86,600

12,836

6,788

540

-874

-898

-867

941

-449

825

592

1,190

2,464

1,926

1,946

-27,038

-1,546

-3,679

-3,451

24,294

0

0

0

Inventory

10,121

5,731

2,933

3,981

2,580

3,181

4,627

2,946

4,259

3,319

2,514

2,617

832

722

1,170

200

-121

235

-1,754

-418

-93

-509

2,112

2,345

2,406

2,890

1,764

681

280

0

0

0

0

-

-

-

-

Current portion of unbilled collaboration revenue

-

-

-

-

-

-

0

0

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Prepaid expenses and other assets

-2,579

5,723

4,469

4,778

21,590

8,525

1,377

3,004

-2,403

378

798

-290

1,506

1,610

1,727

1,927

-421

325

-2,420

-2,051

-159

-1,526

305

-1,036

-5,427

-1,034

1,367

1,286

6,253

1,764

-10,183

-9,814

-11,564

-10,553

0

0

0

Accrued compensation and benefits

-

-

-

-

-

-

0

0

6,266

-

3,928

5,248

8,448

16,705

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accrued clinical trial liabilities

-

-

-

-

-

-

0

0

873

-

1,294

-1,001

-1,657

-3,940

-14,901

-16,891

-14,841

-23,474

-15,314

-8,795

-8,142

6,587

10,060

11,961

19,261

14,398

0

0

0

-

-

-

-

-

-

-

-

Rebates and fees due customers

-

-

-

-

-

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accounts payable, accrued compensation and benefits, and other accrued liabilities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

-2,257

3,407

3,206

8,691

3,189

7,586

3,116

5,149

-11,268

-17,045

-21,888

-14,801

0

0

0

Accrued collaboration liabilities

-

-

-

-

-

-

0

0

5,928

-

-11,619

-11,120

-14,674

-10,938

9,578

9,293

10,976

10,206

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred revenue

862

-9,301

5,411

-983

1,610

271

-8,513

-8,504

-24,046

13,745

25,957

89,449

93,096

256,759

251,513

195,470

198,796

-2,582

-1,319

-1,127

-1,236

1,133

302

-380

-7,968

-14,871

-23,118

-30,441

-30,550

-41,920

-103,472

-220,325

-237,611

-244,528

0

0

0

Other long-term assets

-

-

-

-

-

-

0

0

-103

-

-1,231

-1,497

-817

-1,077

-43

-1,237

-1,696

-1,340

0

0

0

-

-

-

-

-

-

-

1,850

1,966

2,279

51

-175

-405

0

0

0

Accounts payable and other liabilities

14,478

44,124

15,683

18,701

44,841

17,143

25,634

24,298

28,038

26,305

2,023

1,602

-1,008

164

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Long-term portion of lease liabilities

-

-

-

-

-

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Restructuring liability

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

-3,135

-5,404

-4,613

-5,750

3,413

3,890

4,731

5,244

94

1,882

-690

-303

0

0

0

Other current and long-term liabilities

-

-

-

-

-

-

0

0

-22,955

-

4,517

2,335

9,783

1,224

-1,952

-3,253

-7,847

-10,502

-5,906

-5,719

-5,354

-5,295

-1,916

-1,795

-1,776

-1,690

-2,042

-1,676

-1,644

-1,588

-480

-888

-1,017

-1,162

0

0

0

Net cash provided by operating activities

421,437

526,956

473,526

562,768

505,505

415,720

364,482

237,491

168,561

165,611

197,367

153,721

122,452

210,404

90,396

61,944

60,845

-141,051

-156,128

-179,901

-208,405

-235,405

-232,758

-231,747

-216,444

-198,773

-190,180

-167,238

-162,595

-123,146

-113,584

-122,798

-130,923

-159,233

0

0

0

Cash flows from investing activities:
Purchases of property, equipment and other

13,488

12,834

8,469

21,631

32,657

33,297

48,097

34,027

23,286

21,143

4,036

2,918

1,825

1,703

1,449

1,436

1,098

447

136

224

121

474

544

1,113

1,826

2,171

3,268

3,610

3,374

2,717

1,807

932

658

991

0

0

0

Proceeds from sale of property and equipment

-

-

-

-

-

-

-

-

-

-

-

-

-

97

138

163

814

1,346

1,406

1,406

755

392

389

424

419

143

1,106

1,084

1,096

1,943

0

0

0

-

-

-

-

Purchases of investments

1,194,318

1,182,682

1,077,226

849,088

681,164

557,832

439,348

391,293

311,133

319,090

358,724

324,600

444,446

369,187

282,809

297,171

179,945

143,992

129,983

83,465

96,873

119,528

122,444

124,504

129,755

189,975

350,719

521,005

516,264

533,475

386,157

207,998

290,566

237,213

0

0

0

Proceeds from maturities and sales of investments

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from maturities of investments

-

-

-

-

-

-

0

0

301,587

-

317,185

294,038

243,884

151,485

149,230

142,838

154,634

178,936

170,726

166,071

216,990

252,891

286,207

296,540

258,386

325,171

325,912

379,550

407,546

310,765

243,879

199,497

158,397

124,800

0

0

0

Proceeds from sale of investments

-

-

-

-

-

-

0

0

6,238

-

37,294

39,543

39,543

2,266

2,266

17

17

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Purchase of restricted cash and investments

-

-

-

-

-

-

-

-

-

-

-

-

-

-

7,184

5,616

4,970

5,650

2,575

7,684

10,323

8,143

10,484

6,944

6,085

6,085

5,082

45,401

41,485

41,485

0

0

0

-

-

-

-

Proceeds from sale of equity investment

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from maturities of restricted cash and investments

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-5,685

-10,192

-11,045

-19,789

-16,711

-21,824

-24,504

-20,354

-21,697

-18,177

-17,219

-17,268

-17,268

-15,367

-11,642

-5,499

-10,098

-5,899

-6,403

-8,099

0

0

0

Proceeds from other equity investments

-

-

-

-

-

-

0

0

3,189

-

0

0

0

-

-

-

-

95

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net cash provided by (used in) investing activities

-446,970

-587,247

-599,845

-456,636

-379,974

-297,850

-173,384

-136,724

-23,241

36,795

-3,782

10,681

-160,360

-214,548

-131,629

-151,013

-19,503

50,077

56,244

98,861

135,865

146,330

175,659

182,580

138,358

144,351

-14,783

-174,015

-140,839

-259,470

-122,466

51,299

-72,239

-51,463

0

0

0

Cash flows from financing activities:
Proceeds from issuance of common stock under equity incentive plans

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from issuance of common stock, net

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-3

75,643

75,646

75,646

75,646

0

0

138,443

138,489

203,479

203,477

65,034

65,018

179,375

0

0

0

Proceeds from exercise of stock options

-

-

-

-

-

-

0

0

9,755

-

32,563

36,100

34,965

25,327

0

0

0

-

-

-

-

120

167

170

176

72

53

645

836

929

1,632

5,116

8,751

12,436

0

0

0

Taxes paid related to net share settlement of equity awards

10,117

9,904

7,738

7,032

7,025

7,574

6,756

7,208

7,149

6,563

4,407

4,380

3,737

4,108

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Principal payments on financing lease obligation

-

-

-

-

-

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Principal repayments of debt

-

-

-

-

-

-

-

-

-

185,788

186,363

186,363

80,575

575

8,762

8,762

4,598

4,381

-4,757

-5,132

-1,447

-11,709

-12,129

-12,546

-12,858

-13,170

-13,162

-13,158

-14,015

-4,870

-5,713

-7,365

-6,515

-8,621

0

0

0

Other, net

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net cash provided by financing activities

9,472

12,553

14,409

14,746

15,171

9,691

10,122

9,382

-98,314

-169,928

-153,447

-157,017

-54,295

15,696

6,810

156,947

150,553

152,213

145,461

-4,351

-12

65,492

65,148

64,733

64,393

-11,669

-11,826

404,887

404,200

478,428

478,644

64,359

71,577

187,513

0

0

0

Net increase in cash, cash equivalents and restricted cash

-16,061

-47,738

-111,910

120,878

140,702

127,561

201,220

110,149

47,006

32,478

40,138

7,385

-92,203

11,552

-34,423

67,878

191,895

61,239

45,577

-85,391

-72,552

-23,583

8,049

15,566

-13,693

-66,091

-216,789

63,634

100,766

95,812

242,594

-7,140

-131,585

-23,183

0

0

0

Non-cash activities:
Right-of-use assets obtained in exchange for lease obligations

21,968

29,562

12,944

11,338

8,170

17,180

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Unpaid liabilities incurred for purchases of property and equipment

366

26

-320

-11,820

-5,665

802

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Issuance of common stock in settlement of convertible notes

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

-

-

-

-

-

-

-